Clinical efficacy of bosutinib in newly diagnosed CML patients and relapsed, refractory CML patients by carlo gambacorti given during the ESH-iCMLf Pfizer Symposium powered by - MULTIWEBCAST

ESH-iCMLf Pfizer Symposium

LIST OF PRESENTATIONS/COURSES

Webcasted Presentation

BROWSE:

ALL PRESENTATIONS/COURSES

SPEAKERS

PPT SLIDES

VIDEO PODCASTS

Clinical efficacy of bosutinib in newly diagnosed CML patients and relapsed, refractory CML patients

carlo gambacorti

[Biography]

monza, Canada

Disclosure : Research Grant from Wyeth, Pfizer, BMS

[More] [Less]

PRESENTATION

35 slide(s) – 00:16:31 – English – 2011-09-23

Extra Features Available

VIDEO PODCAST

SLIDE LIBRARY

Rate & Comment

A A A


Rate:
Please let us know how useful this content was for you and feel free to write your comments below.

Disclaimer ^{AMENDED ON January 29, 2009} | Technical Support

USER ACKNOWLEDGES AND AGREES THAT ALL DECISIONS MADE WITH THE ASSISTANCE OR USE OF THE SOFTWARE AND/OR THE WEBSITE AND/OR BASED ON CONTENT FOUND HEREIN WILL BE EXCLUSIVELY THE RESPONSIBILITY OF THE USER.

Search’n Build™